Coronary risks after high-dose γ-globulin in children with Kawasaki disease

Pediatrics International

Volumn 42, Issue 5, 2000, Pages 464-469

  Morikawa, Yoshiyuki ^a,j   Ohashi, Yasuo ^h   Harada, Kensuke ^b   Asai, Toshio ^c   Okawa, Sumio ^d   Nagashima, Masami ⁱ   Katoh, Toshiyuki ^e   Baba, Kunizo ^f   Furusho, Kenshi ^g   Okuni, Masahiko ^b   Osano, Mitsuru ^a  

^a KEIO UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^e Nagoya City Higashi General Hospital   (Japan)

^f NISHI KOBE MEDICAL CENTER   (Japan)

^g Kishiwada City Hospital   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ Aichi Prefectural Government   (Japan)

^j Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

more..

Author keywords

Cross validation; Intravenous globulin therapy; Kawasaki disease; Mucocutaneous lymph node syndrome; Risk factor

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MACROGOL;

ARTICLE; CARDIOVASCULAR RISK; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FEVER; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION PROCESS;

CHILD; CORONARY DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; LOGISTIC MODELS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 0033787246     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01288.x     Document Type: Article

References (13)

1. Selection of high risk children for immunoglobulin therapy in Kawasaki disease
2. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
3. Kawasaki disease and gamma globulin: The indication of intravenous gamma globulin
4. A predictive instrument for coronary artery aneurysms in Kawasaki disease
5. A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease
6. Predictive value of statistical models
7. Some diagnostics for binary logistic regression via smoothing
8. Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin
9. High-dose intravenous gamma globulin for Kawasaki disease
10. Evaluation of the cytokine response in Kawasaki disease
11. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome
12. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose